1. Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial. Issue 6 (June 2021) Authors: De Castro, Nathalie; Marcy, Olivier; Chazallon, Corine; Messou, Eugène; Eholié, Serge; N'takpe, Jean-Baptiste; Bhatt, Nilesh; Khosa, Celso; Timana Massango, Isabel; Laureillard, Didier; Chau, Giang Do; Domergue, Anaïs; Veloso, Valdilea; Escada, Rodrigo; Wagner Cardoso, Sandra; Delaugerre, Constan... Journal: Lancet infectious diseases Issue: Volume 21:Issue 6(2021) Page Start: 813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗